Article thumbnail
Location of Repository

The CDKN2A (p16) gene and human cancer

By William D. Foulkes, Tamar Y. Flanders, Pamela M. Pollock and Nicholas K. Hayward

Abstract

CDKN2A, the gene encoding the cell-cycle inhibitor p16CDKN2A, was first identified in 1994. Since then, somatic mutations have been observed in many cancers and germline alterations have been found in kindreds with familial atypical multiple mole/melanoma (FAMMM), also known as atypical mole syndrome. In this review we tabulate the known mutations in this gene and discuss specific aspects, particularly with respect to germline mutations and cancer predisposition

Topics: 111201 Cancer Cell Biology, Carrier Proteins/ genetics, Cyclin-Dependent Kinase Inhibitor p16, Genes, Tumor Suppressor/ genetics, Humans, Mutation, Neoplasms/ genetics
Publisher: The Feinstein Institute for Medical Research
Year: 1997
OAI identifier: oai:eprints.qut.edu.au:45811
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.molmed.org/ (external link)
  • https://eprints.qut.edu.au/458... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.